Erlotinib for metastatic non-small-cell lung cancer: First-, second- or third-line setting - Does it matter? A single-institution experience

Sikander Ailawadhi, Lyudmyla Derby, Raj Natarajan, Gerald Fetterly, Mary Reid, Nithya Ramnath

Research output: Contribution to journalArticle

9 Scopus citations

Fingerprint Dive into the research topics of 'Erlotinib for metastatic non-small-cell lung cancer: First-, second- or third-line setting - Does it matter? A single-institution experience'. Together they form a unique fingerprint.

Medicine & Life Sciences